Issue Date: November 1, 2012
Issued by: Center for Drug Evaluation and Research
Topic(s): Investigation & Enforcement,
Status: Final
CPG Sec. 420.500 *Interference with Compendial Tests* (revised 11/14/2012)
You may submit either electronic or written comments regarding this guidance at any time. Submit electronic comments to http://www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number listed in the notice of availability that publishes in the Federal Register .
Download the Guidance Document
